NCT06699615View on ClinicalTrials.gov

Assessing Perceptions of ML Explanations by Medical Oncologists

NAEnrolling by invitationINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

December 2, 2024

Primary Completion Date

April 15, 2026

Study Completion Date

April 15, 2026

Conditions

Oncology

Interventions

OTHER

Once time de-identified Qualtrics survey

Once time de-identified Qualtrics survey

Trial Locations (1)

19083

University of Pennsylvania, Philadelphia

All Listed Sponsors

lead

Abramson Cancer Center at Penn Medicine

OTHER